Noninvasive Optical QC for Closed Pharmaceutical Systems
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing quality control (QC) devices in healthcare are invasive, unsuitable for closed and sterile systems, and often require substance withdrawal, making them inadequate for real-time, multi-variable testing of pharmaceuticals at the point of use, especially for short half-life products that need immediate safety assurance.
Innovation Solution
A fully automated, noninvasive QC apparatus and method that uses a monitoring device to measure physical, chemical, or optical properties of a substance within a closed system, comparing these values to end-use standards, and includes a processor-controlled release mechanism to ensure sterility and timely delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If invasive QC methods (probes, substance withdrawal) are used to test substance properties, then measurement precision and reliability are improved, but the closed system sterility is compromised and substance loss occurs
Solution Approach 1:
The patent introduces an intermediary optical system that measures substance properties through the container wall without direct contact. The monitoring device uses optical signals (light transmission, absorption, reflection) to detect QC parameters such as concentration, temperature, and pH through the container wall, acting as a mediator between the measurement need and the sterile substance, thereby eliminating probe insertion and substance withdrawal while maintaining sterility and preventing loss.
Solution Approach 2:
The patent replaces mechanical/invasive measurement systems (probes, syringes for substance withdrawal) with non-invasive optical monitoring. Instead of physically contacting the substance with mechanical probes or withdrawing samples, the system uses optical fields to interact with the substance through the container wall, substituting mechanical interaction with electromagnetic field interaction to achieve the same measurement objectives without compromising sterility or causing loss.
2Manufacturing precision
If traditional manufacturer-site QC is performed instead of point-of-use QC, then manufacturing precision is maintained, but the timeliness of safety assurance is delayed for short half-life pharmaceuticals
Solution Approach 1:
The patent implements preliminary QC action by performing all quality control measurements immediately before the substance reaches its point of use or administration. The monitoring device continuously or periodically assesses QC parameters right before administration, ensuring that the substance is verified to be within specifications at the critical moment before patient contact, thereby eliminating the time delay inherent in traditional manufacturer-site QC while maintaining quality standards.
Solution Approach 2:
The patent establishes a real-time feedback loop where QC parameter measurements are immediately processed and compared against predetermined acceptance criteria. The processor receives data from the monitoring device, evaluates whether the substance meets quality standards, and provides immediate feedback on its suitability for administration. This closed-loop feedback system enables rapid decision-making at the point of use, eliminating the time lag of traditional QC workflows.
3Reliability
If multiple QC parameters are tested simultaneously in real-time, then reliability of safety assurance is improved, but device complexity increases
Solution Approach 1:
The patent employs a universal monitoring device capable of measuring multiple different QC parameters (concentration, temperature, pH, viscosity, etc.) through a single integrated system. The device uses various optical measurement techniques (absorption spectroscopy, fluorescence, Raman scattering, light scattering) that can detect different substance properties, allowing one device to perform multiple QC functions rather than requiring separate specialized instruments for each parameter, thus reducing overall system complexity while maintaining comprehensive monitoring.
Solution Approach 2:
The patent combines the monitoring device, processor, and release mechanism into an integrated automated system. The processor merges data from multiple QC parameter measurements, evaluates all parameters against acceptance criteria, and automatically controls the release mechanism based on the combined assessment. This merging of functions into a single coordinated system reduces the complexity that would arise from separate independent systems while enhancing reliability through comprehensive real-time evaluation of multiple parameters.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables real-time, multi-variable quality control of pharmaceuticals without substance loss, ensuring safety and efficacy at the point of use, thereby facilitating immediate administration and reducing the need for bedside pharmacists.
Implementation Method 1
the use of absorption spectroscopy to find the concentration of known solutions is well known
Implementation Method 2
infrared pyrometery has been used to noninvasively measure the temperature of a substance
Data Source
AI summary
The present invention provides an apparatus and method for automated quality control of a substance comprising a compartment wherein a substance is located, a monitoring device coupled to the compartment and configured to monitor at least one quality control parameter prior to an end-use of the substance, and a processor coupled to the monitoring device, wherein the monitoring device is configured to communicate data to the processor for comparing at least one quality control parameter to an end-use value, and wherein the processor is further configured to control the release of the substance from the compartment to its end-use.